CG Oncology reports positive first results from the CORE-008 Cohort CX Phase 2 trial of cretostimogene with gemcitabine in high-risk NMIBC by thaan@22fillmore.com | May 15, 2026 | Portfolio News
Ceribell completes commercial launch of seizure monitoring for newborns and children and activates first sites in its delirium detection pilot by thaan@22fillmore.com | May 11, 2026 | Portfolio News
Mobia Medical prices $150M initial public offering and begins trading on Nasdaq under the ticker MOBI by thaan@22fillmore.com | May 7, 2026 | Portfolio News
BioAge Labs reports positive Phase 1 data for oral NLRP3 inhibitor BGE-102 in people with obesity and elevated inflammation by thaan@22fillmore.com | Apr 21, 2026 | Portfolio News
Opna Bio receives FDA Fast Track designation for OPN-6602 in relapsed or refractory multiple myeloma by thaan@22fillmore.com | Apr 15, 2026 | Portfolio News
